Subtype
Colon Neoplasm
CI-CAN-00004992Explore in graph →
Non-malignant271 active trials5 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004992Explore in graph →
Clinical trials
1,560 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01217450 | Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | May 29, 2014 | clinicaltrials |
| NCT00835679 | Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery | terminated | Early Phase 1 | 9 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00159445 | Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 53 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00183833 | Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01099111 | Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders | completed | — | 225 | King Fahad Medical CityOTHER_GOV | 1 | May 22, 2014 | clinicaltrials |
| NCT01116687 | RO4929097 in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00504153 | Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | May 19, 2014 | clinicaltrials |
| NCT00625651 | Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 202 | AmgenINDUSTRY | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00134069 | Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01372553 | Guilford Genomic Medicine Initiative (GGMI)(GGMI) | completed | — | 1,184 | The Moses H. Cone Memorial HospitalOTHER | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01233505 | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 16 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00088933 | Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 31, 2014 | clinicaltrials |
| NCT01320267 | Single Port Laparoscopic Colectomy(SILS) | withdrawn | Phase 1 / Phase 2 | 0 | University of British ColumbiaOTHER | 0 | Mar 17, 2014 | clinicaltrials |
| NCT02076529 | Phamacokinetic and Pharmacodynamic Study of Ramosetron in Chemotherapy Induced Nasea and Vomiting | completed | N/A | 51 | Chonnam National University HospitalOTHER | 1 | Mar 3, 2014 | clinicaltrials |
| NCT01401309 | PET Respiratory Gating to Detect Hepatic Metastasis in Patients With Colon Cancer | completed | — | 81 | Southwestern Regional Medical CenterOTHER | 1 | Feb 21, 2014 | clinicaltrials |
| NCT00630786 | Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study | completed | Phase 1 / Phase 2 | 53 | AmgenINDUSTRY | 0 | Feb 6, 2014 | clinicaltrials |
| NCT01056913 | NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal Surgery | completed | Phase 4 | 62 | St John of God Hospital, ViennaOTHER | 0 | Jan 29, 2014 | clinicaltrials |
| NCT01403103 | Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer | withdrawn | Early Phase 1 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Jan 17, 2014 | clinicaltrials |
| NCT01385579 | Effectiveness of Direct-to-Patient Outreach on Colorectal Cancer Screening Within a Low Income and Diverse Population | completed | N/A | 202 | Northwestern UniversityOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00756548 | BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy | completed | Phase 3 | 386 | Braintree LaboratoriesINDUSTRY | 1 | Dec 27, 2013 | clinicaltrials |
| NCT01741636 | Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer | completed | N/A | 30 | City of Hope Medical CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00035087 | EPO906 Therapy in Patients With Advanced Colorectal Cancer | completed | Phase 2 | 62 | Novartis PharmaceuticalsINDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT01470235 | Hypodontia and Ovarian Cancer | unknown | — | 200 | University of AarhusOTHER | 1 | Nov 1, 2013 | clinicaltrials |
| NCT01344902 | An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon | terminated | Phase 1 / Phase 2 | 13 | PhotocureINDUSTRY | 1 | Oct 23, 2013 | clinicaltrials |
| NCT00003835 | Combination Chemotherapy in Treating Patients With Stage III Colon Cancer | completed | Phase 3 | 1,260 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00060411 | A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00138177 | Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00147550 | MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma. | terminated | Phase 1 / Phase 2 | 79 | PfizerINDUSTRY | 1 | Sep 13, 2013 | clinicaltrials |
| NCT01929499 | Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer(CIKCC) | unknown | Phase 2 | 210 | Yanjuan ZhuOTHER | 1 | Aug 29, 2013 | clinicaltrials |
| NCT00756977 | BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy | completed | Phase 3 | 394 | Braintree LaboratoriesINDUSTRY | 1 | Aug 15, 2013 | clinicaltrials |
| NCT01541683 | The Effect of Mentholyptus Drops on the Palatability of PEG-Electrolyte Solution | completed | N/A | 99 | American University of Beirut Medical CenterOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00026234 | Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver | completed | Phase 2 | 75 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00003486 | Antineoplaston Therapy in Treating Patients With Colon Cancer | withdrawn | Phase 2 | 0 | Burzynski Research InstituteOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00101270 | Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT01863303 | Epidemiological Study of Colorectal Cancer in WuHan | unknown | — | 1 | Wuhan Pu-Ai HospitalOTHER | 0 | May 27, 2013 | clinicaltrials |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | completed | Phase 2 | 159 | AbbVie (prior sponsor, Abbott)INDUSTRY | 14 | May 15, 2013 | clinicaltrials |
| NCT00381173 | A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing | completed | Phase 1 | 22 | Eisai Inc.INDUSTRY | 1 | May 14, 2013 | clinicaltrials |
| NCT00005036 | Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | completed | Phase 3 | 560 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT01415479 | Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening | completed | N/A | 212 | Indiana UniversityOTHER | 1 | Apr 30, 2013 | clinicaltrials |
| NCT00005094 | Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps | completed | Phase 3 | 1,170 | National Cancer Institute (NCI)NIH | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01826396 | Standard and High Dose Irinotecan Based on UGT1A1 Genotype for First-line Treatment of Locally Advanced Colon Cancer | unknown | Phase 2 | 100 | Colorectal Cancer Institute of the Heilongjiang Academy of Medical SciencesOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00084643 | GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2013 | clinicaltrials |
| NCT00937482 | Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer | terminated | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Mar 8, 2013 | clinicaltrials |
| NCT01436617 | Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab(IgES) | completed | — | 303 | Centre Francois BaclesseOTHER | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT01797770 | Trial on Mechanical Bowel Preparation in Laparoscopic Colorectal Surgery(MBP) | unknown | — | 90 | PVS Memorial HospitalOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT01786200 | Physiological Effects of Altering Cancer-related Inflammation | unknown | N/A | 60 | NHS Greater Glasgow and ClydeOTHER | 1 | Feb 7, 2013 | clinicaltrials |
Data updated 23 days agoSource updated May 29, 2014source: clinicaltrials